Skip to content



Antiretroviral treatment (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress HIV, stop the progression of the disease and reduce HIV related morbidity and mortality. The benefits of ART also include the prevention of HIV transmission. In 2013, WHO launched new Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection

Treatment 2.0 is a WHO/UNAIDS initiative that aims to catalyze HIV treatment scale up, promoting innovation, efficiency, and sustainability through focused work in five priority areas: 1) optimized ARV drug regimens; 2) point of care technology for diagnosis and monitoring; 3) cost reduction; 4) adaptation of delivery systems and 5) community mobilization and participation in the continuum of HIV care. WHO/UNAIDS are working with global and regional partners, technical experts, civil society and other UN co-sponsors to implement this initiative in countries, with short-, medium- and long -term targets and milestones.

More on Antiretroviral treatment in the WHO web page

External Parties Material

Regional Office for the Americas of the World Health Organization
525 Twenty-third Street, N.W., Washington, D.C. 20037, United States of America
Tel.: +1 (202) 974-3000 Fax: +1 (202) 974-3663

© Pan American Health Organization. All rights reserved.